BiotechTube
Home/ForwardVue Pharma/Alan J. Franklin, MD, PhD
AJ

Alan J. Franklin, MD, PhD

Founder and CEO

ForwardVue Pharma

Therapeutic Areas

OphthalmologyRetinal Diseases

ForwardVue Pharma Pipeline

DrugIndicationPhase
Long-acting ORAI1 BlockerRetinal Neovascular Disease (e.g., Diabetic Retinopathy, neovascular AMD)Pre-clinical